| scholarly article | Q13442814 |
| P50 | author | Meritxell Genescà Ferrer | Q42843555 |
| P2093 | author name string | Christopher J Miller | |
| Linda Fritts | |||
| Michael B McChesney | |||
| Zhong-Min Ma | |||
| Mars Stone | |||
| Shelley Blozois | |||
| P2860 | cites work | Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. | Q45753829 |
| Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys. | Q45756492 | ||
| Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. | Q45785662 | ||
| The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo | Q45785963 | ||
| Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. | Q54068533 | ||
| Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon | Q72992207 | ||
| Live attenuated AIDS viruses as vaccines: promise or peril? | Q33776149 | ||
| Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time | Q33787256 | ||
| Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. | Q33802066 | ||
| Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells | Q33806915 | ||
| Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. | Q35877932 | ||
| Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus. | Q35897786 | ||
| Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys. | Q36105923 | ||
| Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6. | Q36105929 | ||
| Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239. | Q36105933 | ||
| A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. | Q36636854 | ||
| Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques | Q36942556 | ||
| Macaques vaccinated with live-attenuated SIV control replication of heterologous virus | Q36946545 | ||
| With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus. | Q36949843 | ||
| Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. | Q37273233 | ||
| Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef | Q39602002 | ||
| Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection | Q40719269 | ||
| Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251. | Q41184851 | ||
| Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge | Q44111091 | ||
| Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). | Q45391784 | ||
| Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus | Q45591866 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 260-270 | |
| P577 | publication date | 2009-08-03 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Limited dissemination of pathogenic SIV after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus | |
| P478 | volume | 392 |
| Q36155560 | Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques |
| Q35250925 | Characterization of an effective CTL response against HIV and SIV infections |
| Q37856708 | Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems |
| Q36760147 | Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies |
| Q33547467 | Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus. |
| Q33725546 | Extralymphoid CD8+ T cells resident in tissue from simian immunodeficiency virus SIVmac239{Delta}nef-vaccinated macaques suppress SIVmac239 replication ex vivo |
| Q27323257 | In captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiome |
| Q35353641 | Increased inherent intestinal granzyme B expression may be associated with SIV pathogenesis in Asian non-human primates. |
| Q36154801 | Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge. |
| Q35826525 | Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 va |
| Q36827361 | Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys |
| Q33767191 | New directions for HIV vaccine development from animal models |
| Q34548621 | Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities |
| Q28818806 | Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine |
| Q37810622 | Role of Semen in HIV‐1 Transmission: Inhibitor or facilitator? |
| Q92736069 | T Cells in the Female Reproductive Tract Can Both Block and Facilitate HIV Transmission |
| Q33666002 | Use of nonhuman primate models to develop mucosal AIDS vaccines |
| Q35022735 | Viral RNA levels and env variants in semen and tissues of mature male rhesus macaques infected with SIV by penile inoculation |
Search more.